Senhwa Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	825.71	1,026	1,319	1,619	2,033	2,369
Cash & Short-Term Investments	825.71	1,026	1,319	1,619	2,033	2,369
Cash Growth	-24.17%	-22.20%	-18.55%	-20.34%	-14.19%	182.89%
Accounts Receivable	0.09	-	-	-	0.19	-
Other Receivables	0.11	0.18	10.59	8.64	7	6.4
Receivables	0.21	0.18	10.59	8.64	7.18	6.4
Prepaid Expenses	9.25	8.69	6.74	5.51	1.62	3.38
Other Current Assets	-	-	-	4.18	3.35	4.91
Total Current Assets	835.16	1,035	1,336	1,637	2,045	2,383
Property, Plant & Equipment	25.36	17.2	14.37	15.75	15.42	9.9
Long-Term Investments	0	0	0.13	0.13	0.13	0.13
Other Intangible Assets	0.07	0.14	0.23	-	0.07	-
Other Long-Term Assets	15.32	13.78	12.46	1.54	1.32	1.88
Total Assets	875.91	1,066	1,363	1,655	2,062	2,395
Accrued Expenses	10.78	21.58	32.37	22.04	75.63	47.59
Current Portion of Long-Term Debt	-	-	-	-	-	7.2
Current Portion of Leases	9.11	7.16	6.31	8.18	5.17	4.18
Current Income Taxes Payable	-	0.14	-	-	-	-
Other Current Liabilities	2.09	2.21	4.2	2.73	1.43	2.3
Total Current Liabilities	21.98	31.09	42.89	32.95	82.23	61.27
Long-Term Debt	-	-	-	-	-	2.06
Long-Term Leases	15.12	7.84	3.29	7.98	10.21	5.67
Total Liabilities	37.1	38.93	46.18	40.93	92.44	68.99
Common Stock	897.04	897.44	897.44	897.44	897.44	896.58
Additional Paid-In Capital	175.5	469.58	765.88	1,116	1,444	1,790
Retained Earnings	-185.21	-293.87	-296.31	-349.63	-329.26	-354.88
Treasury Stock	-49.36	-51.35	-51.35	-51.35	-38.11	-1.99
Comprehensive Income & Other	0.86	5.24	1.49	1.35	-5.24	-3.39
Shareholders' Equity	838.82	1,027	1,317	1,614	1,969	2,326
Total Liabilities & Equity	875.91	1,066	1,363	1,655	2,062	2,395
Total Debt	24.23	15	9.6	16.16	15.38	19.11
Net Cash (Debt)	801.48	1,011	1,309	1,603	2,017	2,349
Net Cash Growth	-25.24%	-22.78%	-18.33%	-20.54%	-14.14%	183.16%
Net Cash Per Share	8.99	11.34	14.68	17.97	22.50	29.75
Filing Date Shares Outstanding	89.19	89.19	89.19	88.63	89.31	89.62
Total Common Shares Outstanding	89.19	89.19	89.19	88.63	89.31	89.62
Working Capital	813.18	1,004	1,293	1,605	1,963	2,322
Book Value Per Share	9.41	11.52	14.77	18.21	22.05	25.96
Tangible Book Value	838.75	1,027	1,317	1,614	1,969	2,326
Tangible Book Value Per Share	9.40	11.51	14.77	18.21	22.05	25.96

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.